Raw data and SPSS analysis for the article Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: Incidence and antimicrobial stewardship

The attached data is related to a study with proposes to investigate the
burden of bacterial and fungal co-infections outcomes on COVID-19
patients. It is a single-center cross-sectional study of hospitalized
COVID-19 patients at Beit-Jala hospital in Palestine. The study included
321 hospitalized patients admitted to the ICU between June 2020 and March
2021 aged ≥20 years, Background: Diagnosis of co-infections with multiple
pathogens among hospitalized COVID-19 patients can be jointly challenging
and very essential for appropriate treatment, shortening hospital stay and
preventing antimicrobial resistance. This study proposes to investigate
the burden of bacterial and fungal co-infections outcomes on COVID-19
patients. It is a single center cross-sectional study of hospitalized
COVID-19 patients at Beit-Jala hospital in Palestine. Methods: The study
included 321 hospitalized patients admitted to the ICU between June 2020
and March 2021 aged ≥20 years, with a confirmed diagnosis of COVID-19 via
RT-PCR conducted on a nasopharyngeal swab. The patient's information
was gathered using graded data forms from electronic medical reports.
Results: The diagnosis of bacterial and fungal infection was proved
through the patient`s clinical presentation and positive blood or sputum
culture results. All cases had received empirical antimicrobial therapy
before the ICU admission, and different regimens during the ICU stay. The
rate of bacterial co-infection was 51.1%, mainly from gram-negative
isolates (Enterobacter species and K.pneumoniae). The rate of fungal
co-infection caused by A.fumigatus was 48.9%, and the mortality rate was
8.1%. However, it is unclear if it had been attributed to SARS-CoV-2 or
coincidental.